https://pubmed.ncbi.nlm.nih.gov/41660850/
Genetic basis of cefiderocol resistance in Acinetobacter baumannii: insights from functional...
Cefiderocol (CFDC) is a siderophore-conjugated cephalosporin that hijacks bacterial iron uptake pathways to traverse the outer membrane, offering potent...
acinetobacter baumanniigeneticbasiscefiderocolresistance
https://pubmed.ncbi.nlm.nih.gov/41360217/
Real-world use of cefiderocol as monotherapy or combination therapy for the treatment of...
Real-world experience supports the role of cefiderocol as a valuable option for GNBIs, with no clinical advantage of combination therapy over monotherapy....
real world use
https://www.cidrap.umn.edu/antimicrobial-stewardship/shionogi-secures-barda-contract-cefiderocol-resistant-infections
Shionogi secures BARDA contract for cefiderocol for resistant infections, bioterror threats | CIDRAP
shionogisecuresbardacontract
https://adisinsight.springer.com/trials/700370702?error=cookies_not_supported&code=f7fd940b-b92b-44cd-b950-0a07e140632d
A phase III trial of cefiderocol - AdisInsight
A phase III trial of cefiderocol for treatment of gram negative infections.
phase iiitrialcefiderocoladisinsight
https://profiles.wustl.edu/en/publications/real-world-experience-with-cefiderocol-therapy-for-pseudomonas-ae/fingerprints/?sortBy=alphabetically
Real-world experience with cefiderocol therapy for Pseudomonas aeruginosa and other multidrug...
real world experience